Clinical Trials › NCT06133049
Active, Not Recruiting
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Sponsored by Bristol-Myers Squibb
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 2961
Target enrollment
1
U.S. states
Mar 2021
Start date
Aug 2031
Expected completion
Interventions / Treatments
OzanimodSelect DMTs other than ozanimodNo DMTs
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Minnesota1 site
Eden Prairie
MS centers in Minnesota
Compare treatment centers near a trial site by center type, providers and trials.
View Minnesota centers